Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Retinoid X receptor beta | Starlite/ChEMBL | References |
Rattus norvegicus | Retinoid X receptor alpha | Starlite/ChEMBL | References |
Homo sapiens | retinoic acid receptor, beta | Starlite/ChEMBL | References |
Rattus norvegicus | Retinoic acid receptor alpha | Starlite/ChEMBL | References |
Rattus norvegicus | Retinoic acid receptor gamma | Starlite/ChEMBL | References |
Rattus norvegicus | Peroxisome proliferator-activated receptor alpha | Starlite/ChEMBL | References |
Rattus norvegicus | Retinoid X receptor gamma | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0476 | 0.1012 | 0.5 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0434 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | 0.0807 | 0.8988 | 1 |
Brugia malayi | nuclear hormone receptor | 0.0807 | 0.8988 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0476 | 0.1012 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 1723.8 nM | In vitro evaluation against RXR-alpha/PPAR-gamma in CV-1 cells by cotransfection assay was determined | ChEMBL. | 12954061 |
Efficacy (binding) | = 3 % | In vitro evaluation against RXR-alpha in CV-1 cells by cotransfection assay. | ChEMBL. | 12954061 |
Efficacy (binding) | = 3 % | In vitro evaluation against RXR-alpha in CV-1 cells by cotransfection assay. | ChEMBL. | 12954061 |
Efficacy (binding) | = 23 % | In vitro evaluation against RXR-alpha/PPAR-gamma in CV-1 cells by cotransfection assay. | ChEMBL. | 12954061 |
Efficacy (binding) | = 81 % | In vitro evaluation against RXR-alpha in CV-1 cells by cotransfection assay. | ChEMBL. | 12954061 |
Efficacy (binding) | = 81 % | In vitro evaluation against RXR-alpha in CV-1 cells by cotransfection assay. | ChEMBL. | 12954061 |
Efficacy (binding) | = 104 % | In vitro evaluation against RXR-alpha/PPAR-gamma in CV-1 cells by cotransfection assay. | ChEMBL. | 12954061 |
IC50 (binding) | = 79.9 nM | Invitro evaluation against RXR-alpha in CV-1 cells by cotransfection assay was determined | ChEMBL. | 12954061 |
IC50 (binding) | = 79.9 nM | Invitro evaluation against RXR-alpha in CV-1 cells by cotransfection assay was determined | ChEMBL. | 12954061 |
Ki (binding) | = 29.6 nM | Binding affinity for Retinoic acid receptor RXR-alpha was determined by competing with 3[H]-9-cis-RA | ChEMBL. | 12954061 |
Ki (binding) | = 29.6 nM | Binding affinity for Retinoic acid receptor RXR-alpha was determined by competing with 3[H]-9-cis-RA | ChEMBL. | 12954061 |
Ki (binding) | = 42.1 nM | Binding affinity for Retinoic acid receptor RXR-beta was determined by competing with 3[H]-9-cis-RA | ChEMBL. | 12954061 |
Ki (binding) | = 42.1 nM | Binding affinity for Retinoic acid receptor RXR-beta was determined by competing with 3[H]-9-cis-RA | ChEMBL. | 12954061 |
Ki (binding) | = 73.9 nM | Binding affinity for Retinoic acid receptor RXR-gamma was determined by competing with 3[H]-9-cis-RA | ChEMBL. | 12954061 |
Ki (binding) | = 73.9 nM | Binding affinity for Retinoic acid receptor RXR-gamma was determined by competing with 3[H]-9-cis-RA | ChEMBL. | 12954061 |
Ki (binding) | > 1000 nM | Binding affinity for Retinoic acid receptor alpha was determined by competing with 3[H]-ATRA | ChEMBL. | 12954061 |
Ki (binding) | > 1000 nM | Binding affinity for Retinoic acid receptor alpha was determined by competing with 3[H]-ATRA | ChEMBL. | 12954061 |
Ki (binding) | > 10000 nM | Binding affinity for Retinoic acid receptor beta was determined by competing with 3[H]-ATRA | ChEMBL. | 12954061 |
Ki (binding) | > 10000 nM | Binding affinity for Retinoic acid receptor gamma was determined by competing with 3[H]-ATRA | ChEMBL. | 12954061 |
Ki (binding) | > 10000 nM | Binding affinity for peroxisome Peroxisome proliferator activated receptor alpha was determined | ChEMBL. | 12954061 |
Ki (binding) | > 10000 nM | Binding affinity for Retinoic acid receptor beta was determined by competing with 3[H]-ATRA | ChEMBL. | 12954061 |
Ki (binding) | > 10000 nM | Binding affinity for Retinoic acid receptor gamma was determined by competing with 3[H]-ATRA | ChEMBL. | 12954061 |
Ki (binding) | > 10000 nM | Binding affinity for peroxisome Peroxisome proliferator activated receptor alpha was determined | ChEMBL. | 12954061 |
Synergy (binding) | = 1.6 fold | In vitro snergistic elevation of transcriptional activation in CV-1 cells expressing RAR and RXR with 3 nm TTNBP | ChEMBL. | 12954061 |
Synergy (binding) | = 1.6 fold | In vitro snergistic elevation of transcriptional activation in CV-1 cells expressing RAR and RXR with 3 nm TTNBP | ChEMBL. | 12954061 |
Synergy EC50 (binding) | = 155.8 nM | In vitro evaluation against RXR-alpha/PPAR-gamma in CV-1 cells by cotransfection assay was determined | ChEMBL. | 12954061 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.